MLH1 and glioma: The results showed that there was a significant positive correlation between MLH1, MSH2, MSH6, and PMS2 and MATL1 in PRAD, liver hepatocellular carcinoma (LIHC), lower grade glioma (LGG), and thyroid carcinoma (THCA) (Figure 7A).